Thursday February 20, 2020

Cabinet to assess 20 drugs in 2016 under new rules

Ministers charged with making life or death calls

Susan Mitchell

Deputy Editor and Health Editor

28th August, 2016
HSE director general Tony OBrien Pic:

Twenty expensive new medicines are expected to go to cabinet for approval this year, the Department of Health has said.

Under a radically changed approval process, the government now has to approve expensive medicines before the Health Service Executive (HSE) will pay for them.

New drugs to treat cancer, high cholesterol and cystic fibrosis are at various stages of the assessment process at present. The cumulative cost of these medicines is about €300 million per...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Medical product supply chain could face interruption if virus continues to spread

Aaron Rogan | 4 days ago

Chief executive Paul Reid believes private care should be separate

Daniel Murray | 1 week ago

If an artist in the US can create a credible facial image of a smoker from DNA left on a discarded cigarette butt, imagine the potential power of genomic medicine, the vast awards awaiting those who possess access to genomes, and the potential for misuse where regulation of genetic information is light

Killian Woods | 1 week ago